Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eric Boersma

Showing results (241-250 of 679) with videos related to

Pageof 68
Sort By:
European Heart Journal|January 21, 2006
Patients enrolled in coronary intervention trials are not representative of patients in clinical practice: results from the Euro Heart Survey on Coronary RevascularizationMarjo Hordijk-Trion, Mattie Lenzen, William Wijns, et al.
Cardiology|October 10, 2009
Prediction of 30-day mortality in older patients with a first acute myocardial infarctionTimo Lenderink, Adrián V Hernández, Eric Boersma, et al.
Cardiology|February 5, 2003
Characteristics, treatment and outcome of patients with non-ST-elevation acute coronary syndromes and multivessel coronary artery disease: observations from PURSUIT (platelet glycoprotein IIb/IIIa in unstable angina: receptor suppression using integrelin therapy)Arno Breeman, Nestor Mercado, Mattie Lenzen, et al.
Heart (British Cardiac Society)|September 19, 2006
The additional value of patient-reported health status in predicting 1-year mortality after invasive coronary procedures: a report from the Euro Heart Survey on Coronary RevascularisationMattie J Lenzen, Wilma J M Scholte op Reimer, Susanne S Pedersen, et al.
Journal of Cardiovascular Electrophysiology|September 30, 2005
Determinants of recurrent ventricular arrhythmia or death in 300 consecutive patients with ischemic heart disease who experienced aborted sudden death: data from the Leiden out-of-hospital cardiac arrest studyPhilippine Kiès, Eric Boersma, Jeroen J Bax, et al.
Scientific Reports|December 10, 2025
Sex-based differences in biomarker trajectories in acute coronary syndrome patients from the BIOMArCS studyChristiane Gärtner, Monique E Ten Haaf, K Martijn Akkerhuis, et al.
The American Journal of Cardiology|September 6, 2024
Impact of Stenting Long Lesions on Clinical Outcomes in Patients Presenting With Acute Coronary Syndrome and Multivessel Disease: Data From the BIOVASC TrialHala Kakar, Jacob J Elscot, Annebel de Gier, et al.
The American Journal of Cardiology|June 14, 2003
Individual prediction of functional recovery after coronary revascularization in patients with ischemic cardiomyopathy: the scar-to-biphasic modelVittoria Rizzello, Arend F L Schinkel, Jeroen J Bax, et al.
British Journal of Clinical Pharmacology|January 28, 2021
No association between use of angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers prior to hospital admission and clinical course of COVID-19 in the COvid MEdicaTion (COMET) studyRoos S G Sablerolles, Freija E F Hogenhuis, Melvin Lafeber, et al.
Vascular and Endovascular Surgery|February 11, 2003
Validation of two risk models for perioperative mortality in patients undergoing elective abdominal aortic aneurysm surgeryMiklos D Kertai, Ewout W Steyerberg, Eric Boersma, et al.
Pageof 68

Showing results (241-250 of 679) with videos related to

Sort By:
Pageof 68
European Heart Journal|January 21, 2006
Patients enrolled in coronary intervention trials are not representative of patients in clinical practice: results from the Euro Heart Survey on Coronary RevascularizationMarjo Hordijk-Trion, Mattie Lenzen, William Wijns, et al.
Cardiology|October 10, 2009
Prediction of 30-day mortality in older patients with a first acute myocardial infarctionTimo Lenderink, Adrián V Hernández, Eric Boersma, et al.
Cardiology|February 5, 2003
Characteristics, treatment and outcome of patients with non-ST-elevation acute coronary syndromes and multivessel coronary artery disease: observations from PURSUIT (platelet glycoprotein IIb/IIIa in unstable angina: receptor suppression using integrelin therapy)Arno Breeman, Nestor Mercado, Mattie Lenzen, et al.
Heart (British Cardiac Society)|September 19, 2006
The additional value of patient-reported health status in predicting 1-year mortality after invasive coronary procedures: a report from the Euro Heart Survey on Coronary RevascularisationMattie J Lenzen, Wilma J M Scholte op Reimer, Susanne S Pedersen, et al.
Journal of Cardiovascular Electrophysiology|September 30, 2005
Determinants of recurrent ventricular arrhythmia or death in 300 consecutive patients with ischemic heart disease who experienced aborted sudden death: data from the Leiden out-of-hospital cardiac arrest studyPhilippine Kiès, Eric Boersma, Jeroen J Bax, et al.
Scientific Reports|December 10, 2025
Sex-based differences in biomarker trajectories in acute coronary syndrome patients from the BIOMArCS studyChristiane Gärtner, Monique E Ten Haaf, K Martijn Akkerhuis, et al.
The American Journal of Cardiology|September 6, 2024
Impact of Stenting Long Lesions on Clinical Outcomes in Patients Presenting With Acute Coronary Syndrome and Multivessel Disease: Data From the BIOVASC TrialHala Kakar, Jacob J Elscot, Annebel de Gier, et al.
The American Journal of Cardiology|June 14, 2003
Individual prediction of functional recovery after coronary revascularization in patients with ischemic cardiomyopathy: the scar-to-biphasic modelVittoria Rizzello, Arend F L Schinkel, Jeroen J Bax, et al.
British Journal of Clinical Pharmacology|January 28, 2021
No association between use of angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers prior to hospital admission and clinical course of COVID-19 in the COvid MEdicaTion (COMET) studyRoos S G Sablerolles, Freija E F Hogenhuis, Melvin Lafeber, et al.
Vascular and Endovascular Surgery|February 11, 2003
Validation of two risk models for perioperative mortality in patients undergoing elective abdominal aortic aneurysm surgeryMiklos D Kertai, Ewout W Steyerberg, Eric Boersma, et al.
Pageof 68